Oncology PracticeActive surveillance may be feasible for some advanced RCC patientsAugust 12, 2016Genitourinary CancerRenal Cell Carcinoma
Oncology PracticeSalvage RT may reduce risk of prostate cancer metastasis even at low PSA levelsAugust 8, 2016Genitourinary Cancer
Oncology PracticeGene profile predicts RCC response to nivolumabAugust 4, 2016Genitourinary CancerImmuno-oncologyRenal Cell Carcinoma
Oncology PracticeFirst-in-class agent shows early promise in treating clear cell renal cell carcinomaJuly 27, 2016Genitourinary CancerRenal Cell Carcinoma
Oncology PracticeDisparities in prostate cancer treatment found at both academic and community centersJuly 22, 2016Genitourinary CancerPractice ManagementPatient & Survivor CareBusiness of Medicine
Oncology PracticeFDA grants priority review to nivolumab for head and neck cancerJuly 20, 2016Head & Neck/Thyroid CancersGenitourinary Cancer
Oncology PracticeCabozantinib improves overall survival in renal cell carcinomaJuly 20, 2016Genitourinary CancerRenal Cell Carcinoma
Oncology PracticeSU2C announces researcher-industry collaboration on immunotherapyJuly 13, 2016Genitourinary CancerHead & Neck/Thyroid CancersMelanomaMultiple MyelomaImmuno-oncologyRenal Cell Carcinoma
Oncology PracticeCisplatin-based chemo may be linked to hearing lossJuly 1, 2016Genitourinary CancerPatient & Survivor Care
The Journal of Community and Supportive OncologyGroup-based psychosocial services: assessing outpatient oncology needsJune 29, 2016Breast CancerGenitourinary CancerPatient & Survivor Care
Oncology PracticeEndorectal balloons decrease prostate radiation’s rectal and bowel sequelaeJune 26, 2016Genitourinary CancerGastroenterologyGastrointestinal Cancer
Oncology PracticeEarly results promising for pembrolizumab in combination regimens for NSCLCJune 19, 2016Lung CancerGastroenterologyGenitourinary CancerGastrointestinal Cancer
